Virtual Adcom Vet Says In-Person Events May Be Better For Product Approval Recommendations
Executive Summary
Syndax CEO also says US FDA’s virtual meetings would benefit from having advisory committee members on camera, which may be a technology challenge.
You may also be interested in...
Pandemic Taking Its Toll On The US FDA’s Non-Pandemic Work, Alkermes CEO Says
Last year was not the greatest performance by the agency outside of COVID-19, Richard Pops tells BIO conference.
Televise The COVID-19 Vaccine Advisory Committee Meetings
With the meetings available on television, access can be assured for just about everyone, and the US FDA can avoid another gut punch to its credibility.
COVID-19 Demands Merit A Mention In US FDA's PDUFA Fees Notice For FY 2021
The pandemic's impact was mentioned only in FDA's calculations for fees including those established by PDUFA. In addition to prescription drug applications, PDUFA fees are charged for OTC switch applications and other proposals for ingredients that are not part of an OTC monograph to be made available nonprescription.
Existing Subscriber?
Sign in to continue reading.
Need a specific report? 1000+ reports available
Buy Reports
Need a specific report? 1000+ reports available
Buy Reports
New to Pink Sheet?
Start a free trial today!
Register for our free email digests:
Register for our free email digests: